PRKCD and Sepsis: Administration of the PKCδ peptide inhibitor in our animal model of sepsis decreased pulmonary PKCδ phosphorylation, attenuated lung injury, and improved gas exchange, indicating that PKCδ inhibition is lung protective in sepsis [19,20,24,47].